VF
YARW

Virtu Financial’s Yarrow Bioscience YARW Stock Holding History

Virtu Financial’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-507
Closed -$15K – 2361
2025
Q4 		$15K Buy
+507
New +$10.2K ﹤0.01% 1473
2025
Q2 		– Sell
-391
Closed -$31K – 2076
2025
Q1 		$31K Buy
+391
New +$48.1K ﹤0.01% 1069
2024
Q2 		– Sell
-324
Closed -$50K – 1931
2024
Q1 		$50K Buy
+324
New +$34.9K ﹤0.01% 1029
2022
Q4 		– Sell
-68
Closed -$14K – 2183
2022
Q3 		$14K Sell
68
-4
-6% -$1.28K ﹤0.01% 1477
2022
Q2 		$25K Buy
72
+45
+167% +$18.9K ﹤0.01% 1289
2022
Q1 		$16K Sell
27
-168
-86% -$99.8K ﹤0.01% 1329
2021
Q4 		$179K Buy
195
+75
+63% +$80.5K 0.02% 876
2021
Q3 		$151K Buy
+120
New +$233K 0.01% 1007
2021
Q2 		– Sell
-15
Closed -$93K – 2124
2021
Q1 		$93K Sell
15
-3
-17% -$21.8K 0.01% 1338
2020
Q4 		$105K Sell
18
-17
-49% -$107K 0.01% 1042
2020
Q3 		$212K Buy
+35
New +$204K 0.04% 578
2019
Q4 		$59K Buy
+4
New +$66.7K 0.01% 1182
2018
Q4 		– Sell
-4
Closed -$126K – 2028
2018
Q3 		$126K Buy
+4
New +$123K 0.01% 1157

Other funds holding YARW

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Virtu Financial's YARW Position: Q1 2026 in Review

Virtu Financial sold out of Yarrow Bioscience (YARW) in Q1 2026, closing a stake of 507 shares — an estimated $15K sold.

Virtu Financial first reported a position in YARW in Q3 2018 and held it in 13 quarters. The position peaked at $212K in Q3 2020. 42 funds tracked by Wall St. Rank hold YARW as of Q1 2026.

  • Virtu Financial reported no remaining Yarrow Bioscience position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 507 Yarrow Bioscience shares in Q1 2026, an estimated $15K.
  • Virtu Financial first reported a position in Yarrow Bioscience in Q3 2018 and held it in 13 quarters.
  • Virtu Financial's Yarrow Bioscience position peaked at $212K in Q3 2020.
  • 42 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.